2018
DOI: 10.1002/hep.29738
|View full text |Cite
|
Sign up to set email alerts
|

Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4–MMP1 axis

Abstract: Our study demonstrates that the CIC-ETV4-MMP1 axis is a regulatory module controlling HCC progression. (Hepatology 2018;67:2287-2301).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
87
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 75 publications
(92 citation statements)
references
References 51 publications
(130 reference statements)
5
87
0
Order By: Relevance
“…To examine the detailed mechanisms underlying M2 macrophages' role in regulating HCC cells invasion and migration, we tested the expression of proteins that have been connected with cancer cell invasion and migration [12][13][14][15][16][17][18] in both culture alone and in co-culture. The exploratory experiments led to the focus on MMP9 as the results showed that MMP9 protein expression was increased after co-culture, both in SK-HEP-1 and HA22T HCC cells ( Fig.…”
Section: Mechanism Dissection Of How M2 Macrophages Increase the Hcc mentioning
confidence: 99%
“…To examine the detailed mechanisms underlying M2 macrophages' role in regulating HCC cells invasion and migration, we tested the expression of proteins that have been connected with cancer cell invasion and migration [12][13][14][15][16][17][18] in both culture alone and in co-culture. The exploratory experiments led to the focus on MMP9 as the results showed that MMP9 protein expression was increased after co-culture, both in SK-HEP-1 and HA22T HCC cells ( Fig.…”
Section: Mechanism Dissection Of How M2 Macrophages Increase the Hcc mentioning
confidence: 99%
“…However, T cellspecific Cic null mice did not show T-ALL phenotypes up to 14 months of age 33 , suggesting that the loss of CIC in T cells may be insufficient to cause T-ALL, and CIC deficiency in other types of immune cells may contribute to disease onset in mice. Decreased CIC expression at the protein level is frequently observed in various types of cancer [19][20][21]28,46 . Moreover, the CIC protein levels are often not correlated with the mRNA levels within the same cancer samples, suggesting that CIC exhibits robust post-transcriptional regulation in cancer cells 19,21 .…”
Section: Cancermentioning
confidence: 99%
“…Decreased CIC expression at the protein level is frequently observed in various types of cancer [19][20][21]28,46 . Moreover, the CIC protein levels are often not correlated with the mRNA levels within the same cancer samples, suggesting that CIC exhibits robust post-transcriptional regulation in cancer cells 19,21 . Nuclear expression of CIC decreases gradually as prostate cancer (PC) becomes more aggressive 20 .…”
Section: Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…CIC is a high mobility group (HMG) box‐containing transcriptional repressor and preferentially binds to T(G/C)AATG(G/A)A DNA sequences through the HMG box in conjunction with the C1 domain . Although several studies have identified dozens of CIC target genes in mammalian cells, the polyoma enhancer activator 3 ( PEA3 ) group genes (ETS translocation variant [ ETV ] 1 , ETV4 , and ETV5 ) are the CIC target genes that have been most extensively studied in various types of cells, including CD4 + T cells . In mammals, CIC has been implicated in regulation of spinocerebellar ataxia type 1 neurodegeneration, lung alveolarization, learning and memory, and cancer progression .…”
mentioning
confidence: 99%